Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing

Nikolajs Zeps, Tamra Lysaght*, Ruth Chadwick, Alexandre Erler, Roger Foo, Simona Giordano, Poh San Lai, G. Owen Schaefer, Vicki Xafis, Wei Leong Chew, Jeremy Sugarman

*此作品的通信作者

研究成果: Short survey同行評審

2 引文 斯高帕斯(Scopus)

摘要

Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.

原文English
頁(從 - 到)1652-1655
頁數4
期刊Stem Cell Reports
16
發行號7
DOIs
出版狀態Published - 13 7月 2021

指紋

深入研究「Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing」主題。共同形成了獨特的指紋。

引用此